Today: 9 June 2026
Browse Category

NYSE:BX 19 July 2025 - 23 October 2025

Blackstone (BX) Shines With Big Q3 Beat & $18B Hologic Deal – But Why Are Shares Falling?

Blackstone (BX) Shines With Big Q3 Beat & $18B Hologic Deal – But Why Are Shares Falling?

Blackstone reported Q3 distributable EPS of $1.52, up 48% year-over-year and above estimates, but GAAP EPS fell to $0.80 as revenue dropped 15.7% to $3.09 billion. Shares traded near $160 on Oct. 23, down about 1% intraday and 6% below 2025 highs. Blackstone and TPG agreed to buy Hologic for $18.3 billion, offering a 46% premium. The firm also launched a $5 billion GCC logistics platform with Lunate.
23 October 2025
···
Blackstone & TPG in $18B Hologic Takeover Shock – Women’s Health Stock Skyrockets

Blackstone & TPG in $18B Hologic Takeover Shock – Women’s Health Stock Skyrockets

Blackstone and TPG will acquire Hologic for $76 per share in cash plus a contingent value right worth up to $3, valuing the deal at $18.3 billion including debt. Hologic’s board approved the offer, which represents a 46% premium to its pre-deal price. Abu Dhabi Investment Authority and Singapore’s GIC will co-invest. Hologic shares rose about 7% on the news; the deal is expected to close in the first half of 2026.
21 October 2025
····
AI Models Are Scheming – Inside OpenAI’s Plan to Stop Deceptive AI Behavior

How to Invest in OpenAI in 2025: All the Ways to Own a Stake in ChatGPT’s Creator

A secondary share sale in October 2025 valued OpenAI at $500 billion, making it the world’s most valuable startup. OpenAI remains private, with no public stock available. Microsoft, SoftBank, and NVIDIA hold major stakes, offering indirect exposure through their shares. The ARK Venture Fund also gives retail investors partial access to OpenAI’s growth.
3 October 2025
········
AI’s Big Bang: Billion-Dollar Deals, Breakthroughs & Backlash (Aug 4–5, 2025 AI Roundup)

AI’s Big Bang: Billion-Dollar Deals, Breakthroughs & Backlash (Aug 4–5, 2025 AI Roundup)

OpenAI raised $8.3 billion at a $300 billion valuation in a round led by Dragoneer, with SoftBank committing up to $40 billion this year. AI-driven M&A hit $2.6 trillion in the first seven months of 2025, up 28% in value despite fewer deals. Italy launched an antitrust probe into Meta over WhatsApp AI integration. California’s new AI hiring rules take effect October 1, 2025.
5 August 2025
············
AI Frenzy: Billion-Dollar Deals, Breakthroughs & Backlash (Aug 3–4, 2025)

AI Frenzy: Billion-Dollar Deals, Breakthroughs & Backlash (Aug 3–4, 2025)

The EU AI Act’s governance standards, GPAI classification, and sanctions regime took effect August 2, as Google signed the EU’s voluntary AI Code of Practice and Meta declined. In the U.S., a Senate plan for a five-year moratorium on state AI laws drew opposition from 17 Republican governors. OpenAI raised $8.3 billion at a $300 billion valuation. A Florida jury awarded $243 million to a family in a Tesla Autopilot crash case.
4 August 2025
··········
Tech Turmoil: Crypto Hits $4 Trillion, SpaceX’s 8,000 Satellites & More Non-AI Bombshells (July 18–19, 2025)

Tech Turmoil: Crypto Hits $4 Trillion, SpaceX’s 8,000 Satellites & More Non-AI Bombshells (July 18–19, 2025)

Defense Secretary Pete Hegseth ordered Microsoft to end China-based engineering on Pentagon cloud projects in July 2025, with the company confirming all technical support from China ended immediately. Blackstone exited the TikTok US sale bid as the forced divestment deadline moved to Sept. 17. India summoned Google and Meta executives over illicit betting ads. Nvidia shares fell 4% after criticism of resumed China exports and new chip plans.
19 July 2025
··········
1 2 3

Stock Market Today

  • Great Western Mining Issues TR-1 Major Shareholder Disclosure
    June 9, 2026, 10:36 AM EDT. Great Western Mining (GWMOF) announced a TR-1 notification of major holdings on June 9, 2026, via the Regulatory News Service (RNS) in Dublin. This disclosure highlights significant shareholdings in the company, providing investors with transparency on ownership stakes. The official document detailing the holdings is accessible via the London Stock Exchange website, ensuring market participants can review the full data. Such filings comply with regulatory requirements to keep the market informed of notable shareholder positions and maintain market integrity. The TR-1 form is a standard channel for reporting these substantial holdings in UK-listed companies.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
Go toTop